Differential Target Multiplexed Spinal Cord Stimulation
NCT ID: NCT05068011
Last Updated: 2024-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2021-10-06
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
NCT05861609
Subthreshold SCS or BMT
NCT05169047
EEG Mapping During High Frequency/High Density Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome
NCT02751216
High-density in Spinal Cord Stimulation: Virtual Expert Registry
NCT02787265
Return to Work for Persistent Spinal Pain Syndrome Type II Patients
NCT05269212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spinal cord stimulation
Patients will receive differential target multiplexed spinal cord stimulation
Spinal Cord Stimulation
differential target multiplexed stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spinal Cord Stimulation
differential target multiplexed stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Patient has been informed of the study procedures and has given written informed consent
* Patient willing to comply with study protocol including attending the study visits
Exclusion Criteria
* History of coagulation disorder, lupus erythematosus, diabetic neuropathy, rheumatoid arthritis, or morbus Bechterew
* Active malignancy
* Addiction to drugs, alcohol (\>5 units per day) and/or medication
* Evidence of an active disruptive psychiatric disorder or other known condition that may impact perception of pain, compliance to the intervention, and/or ability to evaluate treatment outcome as determined by investigator
* Immune deficiency (e.g. HIV positive, immunosuppressive treatment)
* Life expectancy \< 1 year
* Local infection or any other skin disorder at site of incision
* Pregnancy
* Other implanted active medical device
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moens Maarten
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moens Maarten
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium
ZNA
Antwerp, , Belgium
AZ Sint-Jan Brugge-Oostende
Bruges, , Belgium
AZ Sint-Lucas Brugge
Bruges, , Belgium
Jessa Ziekenhuis
Hasselt, , Belgium
AZ Groeninge
Kortrijk, , Belgium
UZ Leuven
Leuven, , Belgium
Heilig Hart Ziekenhuis Lier
Lier, , Belgium
Centre Hospitalier Régional (CHR) de la Citadelle
Liège, , Belgium
AZ Sint-Maarten
Mechelen, , Belgium
AZ Delta
Roeselare, , Belgium
Vitaz
Sint-Niklaas, , Belgium
AZ Turnhout
Turnhout, , Belgium
GZA
Wilrijk, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Michel Turlot, MD
Role: primary
Mayken Gorissen, MD
Role: primary
Mayken Gorissen, MD
Role: primary
Mark Plazier, MD, PhD
Role: primary
Pieter-Jan Germonpre, MD
Role: primary
Tom Theys, MD, PhD
Role: primary
Sofie Denkens, MD
Role: primary
Thibault Remacle, MD, PhD
Role: primary
Johan Vangeneugden, MD
Role: primary
Bart Billet, MD
Role: primary
Jean-Pierre Van Buyten, MD, PhD
Role: primary
Bart Bryon, MD
Role: primary
Raf Van Paesschen, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Goudman L, De Smedt A, Eldabe S, Rigoard P, Billot M, Roulaud M; DETECT consortium; Moens M. Differential target multiplexed spinal cord stimulation in patients with Persistent Spinal Pain Syndrome Type II: a study protocol for a 12-month multicentre cohort study (DETECT). BMJ Open. 2024 Nov 9;14(11):e083610. doi: 10.1136/bmjopen-2023-083610.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DETECT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.